<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Significant innovations have defined the approach to the proximal thoracic aorta </plain></SENT>
<SENT sid="1" pm="."><plain>Aortic proteolysis predisposes to dissection and <z:hpo ids='HP_0002617'>aneurysm</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="6541">Losartan</z:chebi> may prevent aortic root dilation in <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The Loeys-Dietz syndrome mandates early aortic intervention </plain></SENT>
<SENT sid="4" pm="."><plain>Because genetic aortopathies have a multicenter registry, further aortic molecular advances are likely </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> intramural <z:mp ids='MP_0008817'>hematoma</z:mp> (IMH) may be due to <z:hpo ids='HP_0002647'>aortic dissection</z:hpo> with unrecognized microintimal tears </plain></SENT>
<SENT sid="6" pm="."><plain>Type-A IMH is often a surgical emergency, whereas type-B IMH often requires medical management </plain></SENT>
<SENT sid="7" pm="."><plain>Because preoperative <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> predicts mortality in type-A dissection, it is logical to classify this disease by ischemic presentation </plain></SENT>
<SENT sid="8" pm="."><plain>Because advanced age worsens the outcome in type-A dissection, transcatheter interventions should be urgently developed for this high-risk subgroup </plain></SENT>
<SENT sid="9" pm="."><plain>Aortic arch repairs shorter than 45 minutes in duration are safely performed under deep hypothermic <z:e sem="disease" ids="C0444720" disease_type="Disease or Syndrome" abbrv="">circulatory arrest</z:e> with/without perfusion adjuncts </plain></SENT>
<SENT sid="10" pm="."><plain>Bilateral antegrade cerebral perfusion (<z:chebi fb="65" ids="13534">ACP</z:chebi>) offers the best neuroprotection for complex repairs longer than 45 minutes </plain></SENT>
<SENT sid="11" pm="."><plain>Axillary artery cannulation improves outcomes in proximal thoracic aortic procedures </plain></SENT>
<SENT sid="12" pm="."><plain>Contralateral hemispheric <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> is possible with unilateral <z:chebi fb="65" ids="13534">ACP</z:chebi> because cross-cerebral perfusion may be inadequate </plain></SENT>
<SENT sid="13" pm="."><plain>Arch repair with <z:chebi fb="65" ids="13534">ACP</z:chebi> and moderate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HCA</z:e> is safe and effective and represents a research opportunity for pharmacologic ischemic preconditioning </plain></SENT>
<SENT sid="14" pm="."><plain>Antegrade thoracic aortic stenting for DeBakey 1 dissection thromboses the distal false lumen to improve long-term aortic outcomes </plain></SENT>
<SENT sid="15" pm="."><plain>Endovascular arch repair is feasible and may soon be done off-pump </plain></SENT>
<SENT sid="16" pm="."><plain>These described innovations have collectively ushered in a paradigm shift in diseases affecting the ascending aorta and aortic arch </plain></SENT>
</text></document>